n-chlorotaurine has been researched along with Respiratory Tract Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banki, Z; Fenner, J; Kremser, L; Lackner, M; Luttick, A; Müllauer, B; Nagl, M; Rössler, A; Sarg, B; Schwarz, C; Stadtmüller, MN; Stoiber, H; Ströhle, J; Tone, P; Volland, A; von Laer, D; Wolff, T | 1 |
1 other study(ies) available for n-chlorotaurine and Respiratory Tract Infections
| Article | Year |
|---|---|
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19)
Topics: COVID-19 Drug Treatment; Humans; Influenza A Virus, H3N2 Subtype; Respiratory Syncytial Viruses; Respiratory Tract Infections; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Taurine | 2022 |